Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jun;198(6):593-594.
doi: 10.1007/s00066-022-01923-4. Epub 2022 Apr 1.

[Omission of radiotherapy depending on treatment response in children and adolescents with intermediate-stage and advanced-stage Hodgkin lymphoma. Comparison with other consolidation therapies (EuroNet-PHL-C1): a titration study]

[Article in German]
Affiliations
Comment

[Omission of radiotherapy depending on treatment response in children and adolescents with intermediate-stage and advanced-stage Hodgkin lymphoma. Comparison with other consolidation therapies (EuroNet-PHL-C1): a titration study]

[Article in German]
Martin G Sauer. Strahlenther Onkol. 2022 Jun.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Bhatia S, Meadows AT, Robison LL. Family history of patients with breast cancer after treatment of Hodgkin’s disease in childhood. Late effects study group. Lancet. 1997;350:888–889. doi: 10.1016/S0140-6736(05)62074-0. - DOI - PubMed
    1. Schellong G, Potter R, Bramswig J, Wagner W, Prott FJ, Dorffel W, et al. High cure rates and reduced long-term toxicity in pediatric Hodgkin’s disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian pediatric Hodgkin’s disease study group. J Clin Oncol. 1999;17:3736–3744. doi: 10.1200/JCO.1999.17.12.3736. - DOI - PubMed
    1. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059–3068. doi: 10.1200/JCO.2013.54.8800. - DOI - PMC - PubMed
    1. Behringer K, Mueller H, Goergen H, Thielen I, Eibl AD, Stumpf V, et al. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. J Clin Oncol. 2013;31:231–239. doi: 10.1200/JCO.2012.44.3721. - DOI - PubMed

Substances